Literature DB >> 18713830

VRK1 phosphorylates CREB and mediates CCND1 expression.

Tae-Hong Kang1, Do-Young Park, Wanil Kim, Kyong-Tai Kim.   

Abstract

Vaccinia virus B1 kinase plays a key role in viral DNA replication. The homologous mammalian vaccinia-related kinases (VRKs) are also implicated in the regulation of DNA replication, although direct evidence remains elusive. Here we show that VRK1 regulates cell cycle progression in the DNA replication period by inducing cyclin D1 (CCND1) expression. Furthermore, depletion of VRK1 in human cancer cells reduces the fraction of cells in S phase at a given time. VRK1 specifically enhances activity of the cAMP-response element (CRE) in the CCND1 promoter by facilitating the recruitment of phospho-CREB to this locus. VRK1 phosphorylates CREB at Ser133 in vitro and the expression of a kinase-dead mutant of VRK1 or knockdown of VRK1 using siRNA fails to activate CREB and subsequently activate CRE. Finally, we show that VRK1 is a critical link in the CCND1 gene expression pathway stimulated by Myc overexpression. Our results indicate that VRK1 is a novel regulator of CCND1 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713830     DOI: 10.1242/jcs.026757

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  48 in total

1.  Macro histone H2A1.2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphase.

Authors:  Wanil Kim; Goutam Chakraborty; Sangjune Kim; Joon Shin; Choon-Ho Park; Min-Woo Jeong; Nagakumar Bharatham; Ho Sup Yoon; Kyong-Tai Kim
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

2.  The nuclear envelope at a glance.

Authors:  Katherine L Wilson; Jason M Berk
Journal:  J Cell Sci       Date:  2010-06-15       Impact factor: 5.285

3.  VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer.

Authors:  Isabel F Fernández; Sandra Blanco; José Lozano; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

4.  Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage.

Authors:  Marta Sanz-García; Diana M Monsalve; Ana Sevilla; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

5.  NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity.

Authors:  Joon Shin; Goutam Chakraborty; Nagakumar Bharatham; Congbao Kang; Naoya Tochio; Seizo Koshiba; Takanori Kigawa; Wanil Kim; Kyong-Tai Kim; Ho Sup Yoon
Journal:  J Biol Chem       Date:  2011-05-03       Impact factor: 5.157

6.  Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.

Authors:  Annabel T Olson; Amber B Rico; Zhigang Wang; Gustavo Delhon; Matthew S Wiebe
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

7.  Global microRNA characterization reveals that miR-103 is involved in IGF-1 stimulated mouse intestinal cell proliferation.

Authors:  Yalin Liao; Bo Lönnerdal
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

8.  Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia.

Authors:  Matthew S Wiebe; R Jeremy Nichols; Tyler P Molitor; Jill K Lindgren; Paula Traktman
Journal:  Biol Reprod       Date:  2009-08-19       Impact factor: 4.285

9.  Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene.

Authors:  Paul Renbaum; Efrat Kellerman; Ranit Jaron; Dan Geiger; Reeval Segel; Ming Lee; Mary Claire King; Ephrat Levy-Lahad
Journal:  Am J Hum Genet       Date:  2009-07-30       Impact factor: 11.025

10.  Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2.

Authors:  Marta Vázquez-Cedeira; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.